Back to Search
Start Over
Long-Term Outcomes, Genetics, and Pituitary Morphology in Patients with Isolated Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiencies: A Single-Centre Experience of Four Decades of Growth Hormone Replacement.
- Source :
-
Hormone research in paediatrics [Horm Res Paediatr] 2016; Vol. 86 (2), pp. 106-116. Date of Electronic Publication: 2016 Aug 03. - Publication Year :
- 2016
-
Abstract
- Background: Growth hormone (GH) has been used to treat children with GH deficiency (GHD) since 1966.<br />Aims: Using a combined retrospective and cross-sectional approach, we explored the long-term outcomes of patients with GHD, analysed factors influencing therapeutic response, determined persistence into adulthood, investigated pituitary morphology, and screened for mutations in causative genes.<br />Methods: The files of 96 GH-deficient children were reviewed. In a subset of 50 patients, re-assessment in adulthood was performed, including GHRH-arginine testing, pituitary magnetic resonance imaging (MRI), and mutational screening for the growth hormone-1 gene (GH1) and the GHRH receptor gene (GHRHR) in isolated GHD (IGHD), and HESX1, PROP1, POU1F1, LHX3, LHX4, and GLI2 in multiple pituitary hormone deficiency (MPHD) patients.<br />Results: GH was started at a height SDS of -3.2 ± 1.4 in IGHD patients and of -4.1 ± 2.1 in MPHD patients. Relative height gain was 0.3 SDS/year, absolute gain 1.6 SDS, and 1.2/2.6 SDS in IGHD/MPHD, respectively. Mid-parental target height was reached in 77%. Initial height SDS, bone age retardation and duration of GH replacement were correlated with height SDS gain. GHD persisted into adulthood in 19 and 89% of subjects with IGHD and MPHD, respectively. In 1/42 IGHD patients a GH1 mutation was detected; PROP1 mutations were found in 3/7 MPHD subjects. Anterior pituitary hypoplasia, combined with posterior pituitary ectopy and pituitary stalk invisibility on MRI, was an exclusive finding in MPHD patients.<br />Conclusions: GH replacement successfully corrects the growth deficit in children with GHD. While the genetic aetiology remains undefined in most cases of IGHD, PROP1 mutations constitute a major cause for MPHD. Persistence of GHD into adulthood is related to abnormal pituitary morphology.<br /> (© 2016 S. Karger AG, Basel.)
- Subjects :
- Adult
Female
Follow-Up Studies
Homeodomain Proteins genetics
Humans
Kruppel-Like Transcription Factors genetics
LIM-Homeodomain Proteins genetics
Male
Nuclear Proteins genetics
Receptors, Somatotropin genetics
Time Factors
Transcription Factor Pit-1 genetics
Transcription Factors genetics
Zinc Finger Protein Gli2
Hormone Replacement Therapy
Human Growth Hormone deficiency
Human Growth Hormone genetics
Human Growth Hormone therapeutic use
Pituitary Gland metabolism
Pituitary Gland pathology
Pituitary Hormones deficiency
Subjects
Details
- Language :
- English
- ISSN :
- 1663-2826
- Volume :
- 86
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Hormone research in paediatrics
- Publication Type :
- Academic Journal
- Accession number :
- 27487097
- Full Text :
- https://doi.org/10.1159/000448098